Westfield Capital Management CO LP Ascendis Pharma A/S Transaction History

Westfield Capital Management CO LP

  • $19.3 Billion
  • Q1 2025

A detailed history of Westfield Capital Management CO LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Westfield Capital Management CO LP holds 5,479,259 shares of ASND stock, worth $888 Million. This represents 4.42% of its overall portfolio holdings.

Number of Shares
5,479,259
Previous 5,528,239 0.89%
Holding current value
$888 Million
Previous $761 Million 12.21%
% of portfolio
4.42%
Previous 3.52%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$119.49 - $168.84 $5.85 Million - $8.27 Million
-48,980 Reduced 0.89%
5,479,259 $854 Million
Q4 2024

Feb 11, 2025
BUY
$122.0 - $146.6 $48.1 Million - $57.8 Million
394,473 Added 7.68%
5,528,239 $761 Million
Q3 2024

Nov 12, 2024
BUY
$113.0 - $153.43 $19.3 Million - $26.2 Million
170,942 Added 3.44%
5,133,766 $767 Million
Q2 2024

Aug 14, 2024
BUY
$121.07 - $153.67 $107 Million - $136 Million
887,610 Added 21.78%
4,962,824 $677 Million
Q1 2024

May 10, 2024
BUY
$123.45 - $159.4 $5.5 Million - $7.11 Million
44,580 Added 1.11%
4,075,214 $616 Million
Q4 2023

Feb 09, 2024
BUY
$86.1 - $127.36 $19.7 Million - $29.1 Million
228,457 Added 6.01%
4,030,634 $508 Million
Q3 2023

Nov 13, 2023
BUY
$86.5 - $103.97 $14.7 Million - $17.7 Million
170,465 Added 4.69%
3,802,177 $356 Million
Q2 2023

Aug 11, 2023
BUY
$69.96 - $97.84 $34 Million - $47.5 Million
485,586 Added 15.43%
3,631,712 $324 Million
Q1 2023

May 12, 2023
SELL
$104.9 - $126.78 $1.26 Million - $1.53 Million
-12,042 Reduced 0.38%
3,146,126 $337 Million
Q4 2022

Feb 13, 2023
BUY
$99.42 - $131.97 $24.6 Million - $32.7 Million
247,444 Added 8.5%
3,158,168 $386 Million
Q3 2022

Nov 14, 2022
BUY
$84.03 - $110.23 $10.3 Million - $13.5 Million
122,415 Added 4.39%
2,910,724 $301 Million
Q2 2022

Aug 12, 2022
BUY
$78.08 - $117.61 $12 Million - $18 Million
153,282 Added 5.82%
2,788,309 $259 Million
Q1 2022

May 16, 2022
SELL
$102.18 - $135.75 $603,577 - $801,875
-5,907 Reduced 0.22%
2,635,027 $309 Million
Q4 2021

Feb 10, 2022
BUY
$127.1 - $169.66 $67.3 Million - $89.8 Million
529,441 Added 25.07%
2,640,934 $355 Million
Q3 2021

Nov 12, 2021
BUY
$112.67 - $176.92 $10.8 Million - $16.9 Million
95,566 Added 4.74%
2,111,493 $337 Million
Q2 2021

Aug 10, 2021
BUY
$121.62 - $145.29 $18 Million - $21.5 Million
148,234 Added 7.94%
2,015,927 $265 Million
Q1 2021

May 14, 2021
BUY
$124.92 - $173.33 $17.2 Million - $23.9 Million
137,812 Added 7.97%
1,867,693 $241 Million
Q4 2020

Feb 12, 2021
SELL
$151.2 - $182.76 $9.06 Million - $10.9 Million
-59,893 Reduced 3.35%
1,729,881 $289 Million
Q3 2020

Nov 13, 2020
BUY
$134.29 - $154.32 $47.2 Million - $54.2 Million
351,109 Added 24.41%
1,789,774 $276 Million
Q2 2020

Aug 13, 2020
BUY
$110.87 - $156.01 $8.35 Million - $11.8 Million
75,323 Added 5.52%
1,438,665 $213 Million
Q1 2020

May 14, 2020
BUY
$97.01 - $145.11 $9.95 Million - $14.9 Million
102,586 Added 8.14%
1,363,342 $154 Million
Q4 2019

Feb 13, 2020
BUY
$91.45 - $139.12 $12.5 Million - $19 Million
136,702 Added 12.16%
1,260,756 $175 Million
Q3 2019

Nov 08, 2019
BUY
$95.8 - $118.9 $14.6 Million - $18.1 Million
152,302 Added 15.67%
1,124,054 $108 Million
Q2 2019

Aug 13, 2019
BUY
$107.11 - $132.09 $30.5 Million - $37.7 Million
285,207 Added 41.54%
971,752 $112 Million
Q1 2019

May 14, 2019
BUY
$62.15 - $129.99 $9.16 Million - $19.2 Million
147,425 Added 27.35%
686,545 $80.8 Million
Q4 2018

Feb 08, 2019
SELL
$55.16 - $69.67 $2.35 Million - $2.97 Million
-42,614 Reduced 7.33%
539,120 $33.8 Million
Q3 2018

Nov 14, 2018
BUY
$63.77 - $76.28 $10 Million - $12 Million
157,159 Added 37.02%
581,734 $41.2 Million
Q2 2018

Aug 13, 2018
BUY
$58.55 - $73.92 $24.9 Million - $31.4 Million
424,575 New
424,575 $28.2 Million

Others Institutions Holding ASND

# of Institutions
270
Shares Held
61.9M
Call Options Held
151K
Put Options Held
226K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $9.04B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email